|
|
|
|
|
Kanipakam Hema; Sadnala Giribabu; Sandeep Swargam; Amineni Umamaheswari. |
Human pancreatic ribonuclease (RNase1) is a small digestive and pyramidine specific enzyme secreted by the pancreas. RNase1 contributes in the regulation of extracellular RNA by hydrolyzing RNA phosphodiester bonds. High levels of RNase1 in cardiovascular disease patients project the enzyme as an attractive drug target. The known RNase1 inhibitors, citric acid and U1S were searched for structural analogs from Ligand.info database to compile 783 ligands. The ligands' 3D structures and their tautomeric states were generated using LigPrep. The 3424 prepared conformations were subjected to QikProp analysis and filtered based on Lipinski rule of five and zero reactive functional group. The 3376 conformations with good ADME (absorption, desorption,... |
Tipo: Poster |
Palavras-chave: Cancer; Bioinformatics. |
Ano: 2011 |
URL: http://precedings.nature.com/documents/6527/version/1 |
| |
|
|
Navya Pallapotu; Divya M; Kanipakam Hema; Amineni Umamaheswari. |
Peroxisome proliferator-activated receptor (PPAR γ) acts as a key regulator on adipocyte differentiation and glucose homeostasis. PPAR γ has been implicated in the pathology of type 2 diabetes. As human PPAR γ activity is considered important in improving insulin sensitivity, in silico screening was carried out to find potent agonists for human PPAR γ protein. The co-crystal structure of PPAR γ, solved through X-Ray diffraction method was retrieved from the protein data bank. Four PPAR γ agonists selected from literature were submitted to subsequent 2D searching protocol using Ligand.Info, which yielded 1699 structural analogs. The PPAR γ co-crystal structure and ligand dataset were... |
Tipo: Poster |
Palavras-chave: Bioinformatics. |
Ano: 2012 |
URL: http://precedings.nature.com/documents/6957/version/1 |
| |
|
|
Kanipakam Hema; I Vani Priyadarshini; Amineni Umamaheswari. |
IGFBP-2, the largest member of insulin-like growth factor binding proteins family, is under-expressed in hazardous cardiovascular diseases like obesity and type II diabetes mellitus, which upon aging leads to heart stroke. Therefore, IGFBP-2 has been proposed as a possible target for the development of novel leads for cardiovascular disease therapy. High-throughput virtual screening, one of the most common methods used to identify lead compounds was implemented here to identify potential IGFBP-2 activators. The NMR (nuclear magnetic resonance) structure of human IGFBP-2 was retrieved from the protein data bank. A 2D similarity search was performed for known IGFBP-2 activator TPA to acquire 383 structural analogs. The 3D structural conversion and multiple... |
Tipo: Poster |
Palavras-chave: Bioinformatics. |
Ano: 2011 |
URL: http://precedings.nature.com/documents/6570/version/1 |
| |
|
|
Kanipakam Hema; Harika Meduru; Navya Pallapotu; Amineni Umamaheswari. |
Human CK2α2 is an enzyme that belongs to the Serine/Threonine protein kinase family which is involved in signal transduction. Over expression of CK2α2 causes kidney cancer therefore, human CK2α2 has been identified as a drug target for the development of potential antagonists against cancer therapy. The existing human CK2α2 inhibitors in clinical practice are having side effects like fatigue, diarrhea, nausea, anorexia and vomiting. High-throughput virtual screening is one of the most common method used to identify lead compounds was implemented in the present study to identify potential inhibitors of human CK2α2. The co-crystal structure of human CK2α2 was retrieved from the protein data bank. A... |
Tipo: Poster |
Palavras-chave: Bioinformatics. |
Ano: 2012 |
URL: http://precedings.nature.com/documents/6958/version/1 |
| |
|
|
|